| abstract |
Provided herein, inter alia , are septin family proteins as novel biomarkers for the detection of Müllerian cancers such as ovarian, fallopian tube, primary peritoneal, endometrial and uterine cancers as well as therapeutic targeting of septin-2 and other septin family genes and proteins via small molecule, antisense or antibody targeted treatment for treatment of the same. Thus, provided herein are molecular tools and methods for diagnosing Müllerian cancers and for identifying subjects with an increased likelihood of having Müllerian cancers. |